Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
The Journal of Infectious Diseases|May 10, 2002
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionMilos Opravil, Bernard Hirschel, Adriano Lazzarin, et al.
Eclinicalmedicine|May 18, 2023
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trialsPaul E Sax, José R Arribas, Chloe Orkin, et al.
Antiviral Therapy|October 26, 2011
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usageValentina Svicher, Claudia Alteri, Anna Artese, et al.
AIDS Patient Care and Stds|December 22, 2007
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe StudyMaria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, et al.
The Journal of Infectious Diseases|June 2, 2011
Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificityLeonid Gorelik, Carl Reid, Manuela Testa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudinePhilippe Sudre, Jean Philippe Chave, Christian Ruef, et al.
AIDS (London, England)|June 5, 2007
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 yearsMark R Nelson, Christine Katlama, Julio S Montaner, et al.
The New Microbiologica|January 4, 2019
Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected personsAndrea Antinori, Antonio Di Biagio, Simone Marcotullio, et al.
Lancet (London, England)|September 5, 2017
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trialJoel Gallant, Adriano Lazzarin, Anthony Mills, et al.
The New Microbiologica|May 27, 2014
Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodologySimone Marcotullio, Adriana Ammassari, Massimo Andreoni, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Infectious Diseases|May 10, 2002
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionMilos Opravil, Bernard Hirschel, Adriano Lazzarin, et al.
Eclinicalmedicine|May 18, 2023
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trialsPaul E Sax, José R Arribas, Chloe Orkin, et al.
Antiviral Therapy|October 26, 2011
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usageValentina Svicher, Claudia Alteri, Anna Artese, et al.
AIDS Patient Care and Stds|December 22, 2007
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe StudyMaria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, et al.
The Journal of Infectious Diseases|June 2, 2011
Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificityLeonid Gorelik, Carl Reid, Manuela Testa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudinePhilippe Sudre, Jean Philippe Chave, Christian Ruef, et al.
AIDS (London, England)|June 5, 2007
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 yearsMark R Nelson, Christine Katlama, Julio S Montaner, et al.
The New Microbiologica|January 4, 2019
Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected personsAndrea Antinori, Antonio Di Biagio, Simone Marcotullio, et al.
Lancet (London, England)|September 5, 2017
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trialJoel Gallant, Adriano Lazzarin, Anthony Mills, et al.
The New Microbiologica|May 27, 2014
Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodologySimone Marcotullio, Adriana Ammassari, Massimo Andreoni, et al.
Pageof 29